Yong-Su Zhen Selected Research

Yong-Su Zhen Research Topics

Disease

56	Neoplasms (Cancer) 04/2022 - 02/2003
14	Carcinoma (Carcinomatosis) 11/2018 - 07/2004
12	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 07/2004
10	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 06/2007
7	Neoplasm Metastasis (Metastasis) 11/2018 - 12/2003
4	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2008
4	Glioma (Gliomas) 08/2014 - 07/2009
3	Fibrosarcoma 11/2018 - 01/2011
3	Multiple Myeloma 07/2013 - 07/2009
3	Lung Neoplasms (Lung Cancer) 03/2012 - 12/2003
2	Esophageal Squamous Cell Carcinoma 01/2019 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017 - 04/2017
2	Esophageal Neoplasms (Esophageal Cancer) 06/2017 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 11/2016 - 06/2010
2	Colorectal Neoplasms (Colorectal Cancer) 07/2014 - 08/2005
2	Ovarian Neoplasms (Ovarian Cancer) 01/2014 - 01/2009
1	Triple Negative Breast Neoplasms 12/2021
1	Experimental Melanoma 01/2021
1	Inflammation (Inflammations) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2017
1	Adenocarcinoma of Lung 10/2013

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2004
27	C 1027IBA 01/2018 - 06/2005
11	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 06/2005
10	Pharmaceutical PreparationsIBA 03/2022 - 10/2005
9	ErbB Receptors (EGF Receptor)IBA 12/2021 - 01/2009
6	Therapeutic UsesIBA 01/2020 - 07/2005
5	Gemcitabine FDA Link 01/2022 - 05/2008
4	Matrix Metalloproteinases (MMPs)IBA 11/2018 - 12/2003
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 07/2005
4	Collagenases (Collagenase)FDA Link 06/2006 - 12/2003
3	DefensinsIBA 01/2022 - 09/2016
3	Peptides (Polypeptides)IBA 01/2022 - 03/2013
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 02/2011
3	ApoproteinsIBA 01/2018 - 05/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 06/2006
3	Fluorouracil (Carac)FDA LinkGeneric 01/2013 - 07/2004
3	rhein lysinateIBA 01/2009 - 11/2008
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2005 - 07/2004
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2022 - 12/2006
2	Immunoconjugates (Immunoconjugate)IBA 12/2021 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021 - 01/2009
2	Human Serum Albumin FDA LinkGeneric 09/2021 - 01/2018
2	ubenimexIBA 01/2020 - 12/2012
2	Drug CombinationsIBA 01/2020 - 01/2014
2	AlbuminsIBA 01/2018 - 09/2012
2	Temozolomide (Temodar)FDA LinkGeneric 08/2014 - 04/2014
2	GelatinasesIBA 04/2013 - 10/2012
2	Vincristine (Oncovin)FDA LinkGeneric 01/2013 - 12/2004
2	Antineoplastic Agents (Antineoplastics)IBA 01/2013 - 12/2006
2	Fluorescein-5-isothiocyanate (FITC)IBA 10/2012 - 04/2010
2	rheinIBA 01/2009 - 01/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2009 - 01/2009
2	NF-kappa B (NF-kB)IBA 05/2008 - 06/2007
2	UridineIBA 10/2005 - 07/2004
2	Monoclonal AntibodiesIBA 08/2005 - 12/2003
1	formaldehyde-serum albuminIBA 04/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2022
1	salinomycinIBA 01/2022
1	Epithelial Cell Adhesion MoleculeIBA 12/2021
1	ProdrugsIBA 09/2021
1	bleomycetinIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	Gramicidin (Gramicidin A)FDA LinkGeneric 01/2019
1	IonophoresIBA 01/2019
1	Sincalide FDA Link 01/2019
1	Recombinant ProteinsIBA 11/2018
1	Amino Acids FDA Link 01/2018
1	LigandsIBA 06/2017
1	Epidermal Growth Factor (EGF)IBA 06/2017
1	Insulin (Novolin)FDA Link 06/2017
1	Insulin-Like PeptidesIBA 04/2017
1	Amiloride (Midamor)FDA LinkGeneric 02/2017
1	ethylisopropylamiloride (EIPA)IBA 02/2017
1	Neutral RedIBA 02/2017
1	Histone Deacetylase InhibitorsIBA 02/2017
1	EpitopesIBA 01/2017
1	Plicamycin FDA Link 01/2017
1	Sp1 Transcription FactorIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	methoxypolyethyleneglycol- poly(lactic- co- glycolic acid)IBA 01/2017
1	mithramycin AIBA 01/2017
1	GalactosidasesIBA 11/2016
1	IMB5046IBA 11/2016
1	desferrioxamine-human serum albumin conjugateIBA 09/2016
1	TuftsinIBA 12/2014
1	geldanamycinIBA 01/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014
1	Proteasome InhibitorsIBA 07/2013
1	Bortezomib (Velcade)FDA Link 07/2013
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 04/2013
1	NGR peptideIBA 03/2013

Therapy/Procedure

23	Therapeutics 09/2021 - 07/2004
6	Drug Therapy (Chemotherapy) 01/2020 - 12/2004
3	Intravenous Injections 03/2012 - 06/2005
1	Immunomodulation 09/2021
1	Injections 01/2019
1	Immunotherapy 01/2017